Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02

Patrick Y. Wen, Susan M. Chang, Kathleen R. Lamborn, John G. Kuhn, Andrew D. Norden, Timothy F. Cloughesy, H. Ian Robins, Frank S. Lieberman, Mark R. Gilbert, Minesh P. Mehta, Jan Drappatz, Morris D. Groves, Sandro Santagata, Azra H. Ligon, W.K. Alfred Yung, John J. Wright, Janet Dancey, Kenneth D. Aldape, Michael D. Prados, Keith L. Ligon

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalNeuro-oncology
Volume16
DOIs
StatePublished - Apr 1 2014

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Pathology
  • Immunology and Infectious Disease

Cite this